Susquehanna International Group’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $309K | Buy |
|
|||||
|
2025
Q1 | $146K | Buy |
|
|||||
|
2024
Q4 | $102K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $171K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $34.3K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $40.4K | Sell |
|
|||||
|
2023
Q1 | $50.8K | Buy |
|
|||||
|
2022
Q4 | $53.6K | Sell |
|
|||||
|
2022
Q3 | $86K | Buy |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $522K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $782K | Sell |
|
|||||
|
2021
Q1 | $2.42M | Buy |
|
|||||
|
2020
Q4 | $275K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|